<?xml version="1.0" encoding="UTF-8"?>
<p>We would like to share my experience, underlining how migraine patients decided to overcame all the logistical difficulties not to lose the clinical benefit they were experiencing and falling back into the abyss of their migraine attacks. It was only thanks to this context of social and organizational difficulties that we were able to perceive 2 fundamental issues: the first is related to migraine as a real and serious medical problem recognized by patients as extremely affecting on their own life, and the second related to the high efficacy and tolerability of anti‚ÄêCGRP monoclonal antibodies treatment that, finally, has revolutionized the life of subjects with migraine, who can face even dangerous and serious difficulties to have it.</p>
